This pharmaceutical company, operating for several decades, is a prominent player in the European market. Their core focus is on generic and biosimilar medications, catering to a broad spectrum of healthcare needs. Their product portfolio includes prescription drugs, over-the-counter medications, and health and nutrition supplements. Their offerings are available in various dosage forms, including solids, injectables, and liquids. The company holds a strong track record in the industry, with GMP certifications for their production lines in the EU and North America. They also engage in manufacturing for other pharmaceutical companies. Key therapy areas covered by their products include cardiology, oncology, and women's health. Their dedication to quality and extensive product range position them as a leading force in the pharmaceutical landscape.

This pharmaceutical company is a leading manufacturer and exporter with operations spanning over 160 countries, specializing in the development, production, and sale of high-quality generic pharmaceuticals for human use. They have a strong track record of success, having received numerous awards and distinctions including the "European Award for Best Practices" . The company's extensive product portfolio encompasses a wide range of dosage forms and therapy areas, with specific details on these areas, forms, GMP certifications, and patents not provided in the text. Their focus extends beyond prescription medications to include over-the-counter drugs and potentially medical devices or supplements as well.

This EU pharmaceutical company specializes in out-licensing and development services for clients globally. They offer a range of dosage forms including solids, injectables, nasals, creams, and oral liquids across multiple therapy areas. While specific therapy areas aren't listed, they highlight their commitment to quality and accountability, mentioning GMP certifications and product patents. The company operates within the EU and serves markets worldwide.